Skip to content Skip to footer
Ranibizumab: Benefits, Reviews, Info, Side Effects!
Rx Details
Ranibizumab
Lucentis, Lucentis Prefilled Syringe, Ranibizumab Injection
Ranibizumab
Prescription
Antibody
Drugs
Prescription Only
treatment of wet age-related macular degeneration, treatment of diabetic macular edema, treatment of macular edema following retinal vein occlusion, treatment of myopic choroidal neovascularization, improvement of visual acuity, reduction of retinal swelling
Cough, Dizziness, Dry Eyes, Eye Pain, Feeling Of Having Something In The Eye, Headache, Increased Tears, Itching Eyes, Joint Pain, Muscle Pain, Nausea
Ranibizumab is a medication used primarily to treat various eye conditions, such as age-related macular degeneration (AMD), diabetic macular edema, and retinal vein occlusion. The average dosage of ranibizumab typically depends on the specific condition being treated and the formulation used. For most conditions, the standard dosage is 0.5 mg, administered by intravitreal injection into the affected eye once a month (approximately every 28 days). However, there are different dosing regimens, such as less frequent dosing after the initial loading phase, depending on the patient’s response and the specific treatment protocol recommended by the healthcare provider. It’s important to follow the specific dosing instructions provided by a healthcare professional, as they will tailor the treatment to the individual needs of the patient.
Age-related macular degeneration, diabetic macular edema, retinal vein occlusion, myopic choroidal neovascularization
Generally well-tolerated, with rare serious side effects.
No Interactions Reported
$500 – $1,000
$1,850 per vial.

A Synopsis of

Ranibizumab

Ranibizumab is a medication that is commonly used in the treatment of certain eye conditions, particularly age-related macular degeneration (AMD) and diabetic macular edema. It belongs to a class of drugs known as anti-VEGF (vascular endothelial growth factor) agents, which work by blocking the growth of abnormal blood vessels in the eye that can lead to vision loss.

This medication is typically administered through injections directly into the eye by a qualified healthcare provider. While the thought of receiving injections in the eye may sound daunting, rest assured that the procedure is typically well-tolerated and can be performed quickly and efficiently in a clinical setting.

Ranibizumab has been shown to be effective in improving vision and slowing the progression of AMD and diabetic macular edema in many patients. However, like all medications, it may come with potential side effects. These can include temporary discomfort or irritation at the injection site, as well as a small risk of infection or increased eye pressure.

It is important to discuss any concerns or questions you may have about Ranibizumab with your healthcare provider before starting treatment. They can provide you with more information about the medication, its potential benefits, and any possible risks. Additionally, they can monitor your progress and adjust your treatment plan as needed to ensure the best possible outcomes.

Overall, Ranibizumab is a valuable tool in the management of certain eye conditions and has helped many patients preserve their vision and quality of life. If you have been prescribed this medication, be sure to follow your healthcare provider’s instructions carefully and attend all scheduled appointments to optimize your treatment results.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN